Methods:
We assessed men's uptake of paired (separate tests, single blood draw) point-of-care syphilis and HIV tests within a randomized controlled trial of pregnant women who received clinic or home partner HIV testing. We evaluated acceptance of paired HIV-syphilis testing during pregnancy or at 6 months postpartum, and evaluated whether addition of syphilis testing affected the uptake of HIV testing among men.
Results: Of 601 women, we were unable to meet 101 male partners, and 180 tested before syphilis tests were available. Paired syphilis and HIV testing was offered at home to 80 men during pregnancy and to 230 men postpartum. For syphilis, 93% of men agreed to test during pregnancy and 98% agreed postpartum. For paired syphilis and HIV testing, 91% of men tested for both during pregnancy and 96% tested postpartum. Before syphilis test introduction, 96% of men accepted HIV testing, compared with 95% of men who accepted HIV testing when paired testing was offered.
Conclusions: Uptake of syphilis and HIV testing was high among male partners offered couple testing at home. Introducing syphilis testing did not adversely affect HIV testing among men. Point-of-care diagnostics outside facilities can increase testing of male partners who rarely accompany women to antenatal clinics. E ngaging male partners of pregnant women is an important, but often neglected, pillar of maternal and child health program success in sub-Saharan Africa. Despite recent efforts to engage men during their partners' pregnancy, rates of male clinic-based antenatal attendance, including couple human immunodeficiency virus (HIV) testing 1, 2 and antenatal syphilis treatment, [3] [4] [5] are generally low. The effects of male engagement during female pregnancy have mainly been studied in the context of prevention of mother-to-child transmission (PMTCT) of HIV, in which male partner involvement within antenatal care increases male HIV testing 6, 7 and identifies more HIV-discordant couples. 8, 9 Furthermore, male engagement improves women's uptake of PMTCT services 1, 10 and reduces infant HIV acquisition and mortality. 11 Offering male partner syphilis education and testing could lead to similar program improvements and reduce the 930,000 maternal infections and 350,000 syphilis-associated perinatal deaths that occur globally each year. 12, 13 The advent of rapid and inexpensive point-of-care (POC) tests for both HIV and syphilis has expanded test coverage, especially in areas with difficult-to-reach populations or without access to laboratory diagnostics.
14 These novel tools make elimination of congenital syphilis possible, but will likely require high screening coverage and effective partner management strategies. 15 In Kenya, presumptive treatment of male partners of women who tested positive for syphilis during pregnancy led to a reduction of stillbirths and low birth weight babies compared to children of untreated male partners. 16 Syphilis testing can also benefit existing HIV PMTCT efforts as demonstrated in Uganda and Zambia, where addition of syphilis tests led to small but significant increases in HIV testing as well as increased uptake of maternal single-dose nevirapine prophylaxis and combination antiretroviral treatment. 17 Syphilis and HIV testing during pregnancy are highly cost-effective interventions during pregnancy 18, 19 and can be scaled up in lowand high-resource settings. 20 In contrast to low rates of antenatal clinic-based HIV (12-15%) 1, 10, 21 and syphilis testing of male partners (<2%), 3 homebased sexually transmitted infection (STI) education and testing has been shown to be highly acceptable (>83% HIV test uptake) and feasible in several settings in Africa. 8, 22, 23 Additionally, costeffectiveness models in sub-Saharan Africa suggest that paired HIV and syphilis testing strategies, including single-cartridge duplexed HIV-syphilis tests, are cost saving and result in fewer disability-adjusted life-years lost compared with HIV-only testing programs. 19 We examined whether paired POC syphilis and HIV testing at home were acceptable to male partners of pregnant women as part of a randomized controlled trial (RCT). We determined uptake of syphilis and HIV tests during pregnancy and at 6 months postpartum and conducted a comparison of HIV test uptake among male partners before and after the addition of syphilis testing.
METHODS
This was an observational cohort study; study participants were male partners of women who participated in a RCT of homebased partner education and testing (HOPE) that enrolled 601 pregnant women presenting to a first antenatal clinic visit at Kisumu County Hospital in Nyanza Province, Kenya from September 2013 to June 2014. 8 Pregnant women were eligible to enroll in the study if they were married or cohabiting, had not experienced intimate partner violence within the preceding month, aged 14 years or older and living within 40 kilometers of the hospital. Consenting women were randomized to receive either: (1) home-based partner education and HIV testing with their male partner (HOPE intervention, n = 306); or (2) a male partner invitation letter for clinicbased HIV testing at the maternal and child health clinic (control, n = 295). Couples received counseling in the home about family health, including HIV, STI symptoms and clinic-based treatment, syphilis POC tests, exclusive breast feeding, facility delivery and family planning, and were encouraged, but not required, to test together as a couple with mutual disclosure. HIV testing included standard pretest and posttest counseling.
In the larger RCT, staff encountered male partners of the intervention arm at the home-based HOPE intervention visit during pregnancy. Outcomes for all participants of the RCT were then assessed at a home-based 6-month postpartum follow-up visit, at which time men of the control arm were first encountered. This exit visit included HIV testing to determine final infection status. 8 As this is an area of high HIV incidence, men were classified as having unknown HIV status if they did not self-identify as HIV positive.
We assessed uptake of a POC treponemal syphilis test (SD Bioline Syphilis 3.0; Standard Diagnostics Inc., South Korea) when conducted concurrently with rapid HIV testing. First, we examined uptake of first-time offer of syphilis testing within the intervention arm (during pregnancy) and control arm (6 months postpartum) of the RCT. Due to test unavailability at the study start, syphilis tests were offered to intervention participants after some men received HIV-only testing and education during pregnancy. Second, we assessed whether the addition of syphilis testing affected HIV testing, by comparing HIV test uptake during pregnancy before and after syphilis testing was added to the homebased HOPE HIV couple education and testing intervention.
Home-Based Couple Education and Paired HIV-Syphilis Testing Visit
After syphilis testing became available, men could accept HIV and syphilis POC testing together (paired), HIV testing only, syphilis testing only, or no testing. If both tests were chosen, syphilis and HIV testing and results were conducted at the same time utilizing a single finger-prick blood draw. Study staff referred men who tested positive for syphilis to maternal and child health clinics for cost-free intramuscular penicillin treatment per World Health Organization guidelines. All HIV-infected participants were referred to HIV comprehensive care clinics per Kenyan national protocol.
At the 6-month postpartum visit, all participants were offered an exit interview and paired HIV and syphilis testing. Therefore, men in the control arm received STI education and a first offer of syphilis testing at this time, whereas men in the intervention arm were offered repeat testing for HIV and syphilis.
Data Collection and Analysis
Study staff surveyed couples via password-protected mobile phone-based questionnaires in Open Data Kit software. 24 Among men enrolled in the study, first-time syphilis test uptake data proportions were calculated, and HIV test uptake before and after syphilis test introduction was analyzed using chi-square tests. Data were analyzed using Stata 12 (StataCorp LLC, College Station, Texas).
Human Subjects
The study protocol was approved by Kenyatta National Hospital Ethics Review Committee in Nairobi and the Institutional Review Board at the University of Washington. Written informed consent was obtained in Swahili, Luo, or English for all participants before enrollment.
RESULTS

Study Population
Among 601 pregnant women enrolled in the parent RCT, 101 male partners (17%) were not located or did not agree to discuss participation: 46 men (15%) in the HOPE arm and 55 men (19%) in the control arm were never able to be contacted, and 32 women and partners in the control arm (11%) were lost before the postpartum testing visit. Of the remaining 500 male partners, 180 men were enrolled and tested for only HIV before the syphilis test was available. After syphilis testing was available, 320 male partners were enrolled in the study (Fig. 1) . Of these men, 80 in the HOPE arm were offered paired syphilis and HIV testing at home during their partners' pregnancy, and 240 in the control arm were offered paired syphilis-HIV testing at home during a postpartum visit. Test uptake data were missing for 10 men in the control arm.
The median age of participating men was 30 (interquartile range [IQR], 27-35) ( Table 1 ). All were married and 95% were living together with their female partners. Most men had children before the study-enrolled pregnancy, as only 20 (25%) and 36 (22%) were first-time parents in the intervention and control arms, respectively. Among experienced parents with at least one previous child, 21% (11 of 52) of men in the intervention arm and 16% (20 of 127) of men in the control arm attended any ANC visit during the last pregnancy that occurred before female study enrollment.
HIV POC testing was familiar and acceptable to this population of men, and self-disclosure of female HIV testing to their male partners was reported by men to be high. (Table 2) . Reasons for refusing syphilis testing were not available for the three HIV-positive men who refused syphilis testing during the intervention in pregnancy, but were captured among all study participants completing 6-month postpartum visits (intervention and control arms). Of 10 men (1 HOPE, 9 control) who refused syphilis testing, 3 men indicated that they "did not think it is necessary" and 7 men "did not want to know." Refusal options that were not cited included, "not understanding the test," "fearing a test finger prick," or "female partner unwilling to couple test or share results."
Syphilis test positivity among male partners was low in this population with 1.4% (1 of 74) of intervention arm men and 0.9% (2 of 226) of men in the control arm testing positive ( Table 2 ). All three syphilis-positive men were in syphilis-discordant couples as their partners tested negative for syphilis. The man who tested positive for syphilis during pregnancy in the intervention arm had also declined HIV testing and did not know his female partner's HIV status. At 6 months postpartum, he reported that he had sought clinic-based STI services for syphilis treatment during pregnancy and accepted couple HIV testing at the 6-month postpartum visit. He was HIV-negative and his female partner was HIV-positive. The two male partners in the control arm who tested positive for syphilis postpartum were both HIVnegative and their female partners were negative for both HIV and syphilis. Among female partners of all male participants, 1.3% (4 of 310) of couples offered paired testing during pregnancy or postpartum had tested positive for syphilis (1 intervention, 3 control). Overall, syphilis testing revealed a total of 2 intervention and 5 control couples affected by syphilis; all 7 couples were syphilis-discordant.
Considering paired syphilis and HIV testing, first-time uptake of paired syphilis and HIV testing was high among men of unknown HIV status who were eligible for paired testing (Table 2 ). In the intervention arm, of 74 male partners of unknown HIV status, 91% (67) accepted both HIV and syphilis testing, 5.4% (4) accepted syphilis testing only, 4.1% (3) accepted HIV testing only and none refused both tests. In the control arm, of 211 men with unknown HIV status, 96% (204) accepted both HIV and syphilis testing, 1.4% (3) accepted syphilis testing only, none accepted HIV testing only and 1.9% (4) refused both tests. We also assessed the acceptability of syphilis testing among HIVpositive men who were ineligible for HIV testing. Among 25 men who reported known HIV-positive status, 3 of 6 (50%) of men in the HOPE arm and all 19 (100%) of men in the control arm accepted syphilis testing.
Lastly, we examined the effect of adding POC syphilis testing to the home-based HIV test (Table 3) . Among male partners who were eligible for HIV testing, 96% (151 of 158) accepted HIV testing before syphilis test introduction compared to 95% (70 of 74) of men who accepted HIV testing when both HIV and syphilis testing were offered (χ 
DISCUSSION
This study demonstrated high acceptability of both syphilis and HIV testing among male partners of pregnant women when offered together at home in a couple testing environment. Homebased testing visits were accepted by more than 80% of enrolled couples in both pregnancy and postpartum. Of those reached by the intervention, uptake of syphilis testing was nearly as high or higher (93% and 98%) compared with HIV test uptake (95% and 96%) among men with unknown HIV status during early pregnancy and at 6 months postpartum, respectively. Consequently, most men with unknown HIV status accepted both syphilis and HIV testing (91% during pregnancy and 96% postpartum) when offered together at home. We had small numbers of HIV-positive men, who were more likely to decline a syphilis test, which we speculate was due to desire to avoid a blood draw because HIV status was known. The acceptability of syphilis and HIV testing found in this study is higher than findings in prior studies. In neighboring Uganda, where syphilis prevalence is higher (6.2% among males and 4.0% among females), 81% of male partners who sought clinic-based testing after invitation letters accepted both HIV and syphilis testing, 17% accepted only HIV testing, and 1.7% accepted only syphilis testing. 3 In rural Brazil, home-based POC syphilis and HIV testing of were highly acceptable and feasible, with 85% accepting paired HIV-syphilis testing. 25 The higher uptake in our study may be a result of participants' experience with previous HIV testing, as well as the positive effects of homebased couple testing on male partner HIV test uptake. Homebased couple HIV testing is desired by male partners 23 and has resulted in 2-fold greater (87% vs 39%; relative risk = 2.10) HIV test uptake among men during pregnancy compared to clinic-based invitation of the control group. 8 Our qualitative research also shows that home-based testing enables close rapport between counselors and partners in a comfortable home environment that can be more conducive to POC testing than clinicbased options (Krakowiak, submitted) .
In addition to our finding that syphilis testing was acceptable to men of unknown HIV status, it was also acceptable to most HIV-positive men. Among the 25 previously diagnosed HIVpositive male partners, testing acceptance was 50% (3 of 6) among men in the intervention arm and 100% (19 of 19) among men in the control arm. Given the higher prevalence of syphilis among HIV-positive men (6.4%) and women (3.2%) in Kenya, 26 prioritizing syphilis testing among HIV-positive individuals and their partners before and during pregnancy could be a cost-effective approach to preventing antenatal syphilis transmission and adverse pregnancy outcomes and support overall PMTCT program success. 27 Although the prevalence of syphilis in this study was low, it is notable that all 3 men and 4 women testing positive for syphilis were in a syphilis-discordant couple, indicating a high yield for PMTCT of syphilis with successful treatment and repeat testing of both partners. Identification and treatment of male partners throughout pregnancy is critical to successful joint elimination of mother-to-child transmission of syphilis and HIV. This is particularly important among discordant couples with a syphilis positive male partner to prevent adverse pregnancy outcomes or neonatal infections, which occur with 52% greater frequency among untreated mothers with syphilis infection compared to women without syphilis infection. 28 We were unable to determine whether men were more motivated to test for syphilis during pregnancy (to benefit the unborn child) versus in the postpartum period (for their own benefit), as uptake of the test was similar and high during both periods. This suggested that home-based couple counseling, rather than timing, mattered. Men received counseling messages that emphasized both their own general health and the health of their partner and infant as part of counseling encouraging them to test for syphilis and HIV.
Because the syphilis POC test became available halfway through the study, our study design allowed assessment of the effect of introducing syphilis testing to HIV testing. HIV test acceptability among men of unknown HIV status did not change and remained high at 95%, indicating that syphilis test introduction did not negatively affect male partner HIV testing. Similarly, a systematic review found no adverse effects on existing female rapid HIV-testing rates among 6 studies that introduced maternal rapid syphilis testing. 29 In some study sites (Peru, Cambodia, Uganda, and Zambia), maternal HIV testing increased after paired HIV-syphilis testing was introduced.
A strength of this research is the home-based couple testing approach to increasing male partner engagement, which directly recruited male partners of pregnant women. We previously demonstrated that offering home-based couple HIV testing increases HIV testing and identifies more male-positive HIV discordant couples during pregnancy compared to clinic-based couple HIV testing. 8, 22, 23 This current study shows that home-based couple syphilis testing is equally acceptable, and this familycentered approach identifies syphilis discordant couples during a high-risk time for adverse pregnancy outcomes. Additional approaches involving male partners, such as combined phonetracing and home visits in a Malawi study, have been shown to increase clinic-based male participation from 50% to 72% compared to invitation letters alone. 7 A combination of these approaches may provide a cost-effective strategy for scaling up couple-based antenatal services.
Given the success of this strategy and its modest cost, scaleup should be considered in countries seeking to improve HIV and syphilis testing in the antenatal period. Further implementation research would be useful to characterize the minimum factors that may be key to the successful recruitment of male partners, such as financial incentives and use of male counselors.
In summary, home-based POC syphilis testing was as acceptable as HIV testing among male partners of pregnant women in a setting where previous HIV test experience was high and male antenatal attendance was low. New POC diagnostics allow increased access to testing outside of antenatal clinics and may assist men to connect with clinic-based STI treatment. Pairing syphilis and HIV testing is an acceptable and potentially costeffective approach to traditional syphilis control strategies. Diagnosing and successfully treating syphilis among male partners of pregnant women can improve male partner health and reduce adverse pregnancy outcomes, including neonatal syphilis and stillbirths. 
